causal
Analysis v1
People with obesity and another health issue who got a weekly shot of semaglutide plus behavioral therapy lost about 17 kg on average after a year and a half — way more than those who got a placebo.
Evidence from Studies
Supporting (0)
0
Community contributions welcome
No supporting evidence found
Contradicting (1)
0
Community contributions welcome
1
Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment
Narrative Review
2025 Mar 12This study talks generally about how semaglutide helps with weight loss, but doesn’t give the exact numbers the claim uses, so we can’t say it proves those specific numbers are true.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.